Paclitaxel-Hyaluronic NanoConjugates Prolong Overall Survival in a Preclinical Brain Metastases of Breast Cancer Model

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-13-0132
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Breast Cancer With Brain Metastases: Clinicopathologic Features, Survival, and Paired Biomarker Analysis

Oncologist
Cancer ResearchMedicineOncology
2015English

Fruit and Vegetables Don't Prolong Survival in Women With Breast Cancer

BMJ
2007English

Evaluation of Overall Survival Following Stereotactic Radiosurgery (SRS) for Non-Small Cell Lung Cancer Brain Metastases

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Expression of Selected Proteins in Breast Cancer Brain Metastases

Folia Histochemica et Cytobiologica
MedicineForensic MedicinePathologyHistology
2013English

Paclitaxel in Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
1998English

Long-Term Survival and Cure Model Following Liver Resection for Breast Cancer Metastases

Breast Cancer Research and Treatment
Cancer ResearchOncology
2018English

Quality-Adjusted Survival With Nab -Paclitaxel vs Standard Paclitaxel in Metastatic Breast Cancer: A Q-TWiST Analysis

Clinical Breast Cancer
Cancer ResearchOncology
2018English

Risk Factors for Breast Cancer Brain Metastases: A Systematic Review

Oncotarget
Oncology
2020English

Nomograms to Estimate Long-Term Overall Survival and Breast Cancer-Specific Survival of Patients With Luminal Breast Cancer

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy